Outcomes of melanoma in recipients of solid organ transplant.

Background: There is concern that the immunologic tumor malignant melanoma (MM) may have worse outcomes in immunosuppressed hosts than in the general population.

Objective: We sought to describe outcomes of MM in immunosuppressed solid organ transplant recipients and compare them with the general population.

Methods: We conducted a retrospective review of medical charts and pathology slides of cases of MM and solid organ transplantation between 1978 and 2007, with comparison of outcomes.